YBGJ stock

Yubo International Biotech Limited (YBGJ) financials · $8.9M cap

Yubo International Biotech Limited (YBGJ) $8.9M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$12.4K$3.5K
Cost of Revenue$4.2K$822
Gross Profit$8.2K$2.6K
Operating Income-$1.2M-$1.8M
Net Income-$1.1M-$2.0M
EPS (Diluted)$-0.01$-0.02
Cached annual balance sheet
LineFY2025FY2024
Total Assets$847.1K$1.5M
Current Assets$667.5K$682.8K
Cash & Equivalents$8.1K$7.0K
Inventory$24.0K$37.0K
PP&E$43.0K$205.9K
Total Liabilities$2.8M$4.8M
Current Liabilities$2.8M$4.7M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$2.0M-$3.4M
Retained Earnings-$7.7M-$6.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$842.8K-$1.3M
CapEx$0$0
Investing Cash Flow$0$118.4K
Financing Cash Flow$849.5K$1.4M
Dividends Paid$0$0
Net Change in Cash$1.0K$0
Free Cash Flow$0$0

FAQ

What is YBGJ P/E and revenue?

Yubo International Biotech Limited (YBGJ) $8.9M cap.

What is YBGJ revenue?

Yubo International Biotech Limited last cached revenue is $12.4K (FY2025).

Is YBGJ profitable?

Yubo International Biotech Limited last cached net income is -$1.1M.

What are YBGJ total assets?

Yubo International Biotech Limited last cached total assets are $847.1K.

What is YBGJ free cash flow?

Yubo International Biotech Limited last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.